Probiotic infant products
The present invention is directed to an infant formula or children's nutritional product comprising a protein source, a fat source, a carbohydrate source, and B. longum AH1206.
1 . An infant formula comprising a protein source, a fat source, a carbohydrate source, and B. longum AH1206.
2 . The infant formula of claim 1 , wherein the infant formula comprises B. longum AH1206 in the range of about 1×10 4 cfu to about 1×10 10 cfu per gram infant formula.
3 . The infant formula of claim 1 , wherein the infant formula comprises B. longum AH1206 in the range of about 1×10 6 cfu to about 1×10 9 cfu per gram infant formula.
4 . The infant formula of claim 1 , wherein the infant formula comprises at least 1×10 6 cfu B. longum AH1206 per gram infant formula.
5 . The infant formula of claim 1 , wherein the B. longum AH1206 is viable.
6 . The infant formula of claim 1 , wherein the B. longum AH1206 is non-viable.
7 . The infant formula of claim 1 , further comprising an additional probiotic.
8 . The infant formula of claim 7 , wherein the additional probiotic comprises LGG.
9 . The infant formula of claim 1 , further comprising a prebiotic.
10 . The infant formula of claim 9 , wherein the prebiotic is selected from the group consisting of oligosaccharides, polysaccharides, and prebiotics that contain fructose, xylose, soya, galactose, glucose or mannose.
11 . The infant for formula of claim 9 , wherein the prebiotic is selected from the group consisting of lactulose, gluco-oligosaccharide, inulin, polydextrose, galacto-oligosaccharide, fructo-oligosaccharide, isomalto-oligosaccharide, soybean oligosaccharides, lactosucrose, xylo-oligosacchairde, and gentio-oligosaccharides.
12 . The infant formula of claim 1 , further comprising at least one LCPUFA.
13 . The infant formula of claim 1 , further comprising ARA and DHA.
14 . The infant formula of claim 13 , wherein the ratio of ARA:DHA by weight is from about 1:3 to about 9:1.
15 . The infant formula of claim 1 , wherein the infant formula comprises a form selected from the group consisting of a powder, a liquid, and a ready-to-use formulation.
16 . A children's nutritional product comprising a protein source, a fat source, a carbohydrate source, and B. longum AH1206.
17 . A method for reducing or preventing inflammation in an infant or child comprising administering B. longum AH1206 to the infant or child.
18 . The method of claim 17 , wherein the inflammation is reduced or prevented in an area selected from the group consisting of the gastrointestinal tract, the respiratory tract, and systemic inflammation.
19 . The method of claim 17 , wherein the reduction or prevention of inflammation improves allergies.
20 . The method of claim 17 , wherein the reduction or prevention of inflammation improves asthma.
21 . The method of claim 17 , wherein the reduction or prevention of inflammation improves an illness selected from the group consisting of diarrhea, respiratory infections, and otitis media.